Abstract
It has been shown that the agonist of 5HT1A-receptors 8-OH-DPAT induces contraction of aortic rings in the presence of angiotensin II. This effect is not associated with activation of α1-adrenoceptors by 8-OH-DPAT as it is reproduced in the presence of prazosin which completely suppresses the nonspecific vasoconstrictive effect of 8-OH-DPAT via α1-adrenoceptors on the aorta incubated without angiotensin II. Synergism in the action of angiotensin II and 8-OH-DPAT is completely preserved after partial desensitization of the receptors of angiotensin II. It has been found that 8-OH-DPAT increases the free cytoplasmic calcium concentration in cultured smooth muscle cells from the rat aorta. The data obtained support the hypothesis about the existence of “silent” vasoconstrictive 5HT1A-receptors. It has been suggested that activation of these receptors underlies synergism in vasoconstrictive action of serotonin and angiotensin II.
Similar content being viewed by others
References
Bailey, S.R., Eid, A.H., Mitra, S., et al., Rho Kinase Mediates Cold-Induced Constriction of Cutaneous Arteries: Role of alpha2C-Adrenoceptor Translocation, Circ. Res., 2004, vol. 94, no. 10, pp. 1367–1374.
Banes, A.K. and Watts, S.W., Enhanced Contraction to 5-Hydroxytryptamine Is not Due to “Unmasking” of 5-Hydroxytryptamine(1B) Receptors in the Mesenteric Artery of the Deoxycorticosterone Acetate-Salt Rat, Hypertension, 2001, vol. 38, no. 4, pp. 891–895.
Browning, K.N. and Travagli, R.A., The Peptide TRH Uncovers the Presence of Presynaptic 5-Ht1a Receptors via Activation of a Second Messenger Pathway in the Rat Dorsal Vagal Complex, J. Physiol., 2001, vol. 531, no. 2, pp. 425–435.
Chau, N.P., Pithois-Merli, I., Levenson, J., et al., Comparative Haemodynamic Effects of Ketanserin and Ritanserin in the Proximal and Distal Upper Limb Circulations of Hypertensive Patients, Eur. J. Clin. Pharmacol., 1989, vol. 37, no. 3, pp. 215–220.
Chen, J., Yildiz, O., and Purdy, R.E., Phenylephrine Precontraction Increases the Sensitivity of Rabbit Femoral Artery to Serotonin by Enabling 5-HT-Like Receptors, J. Cardiovasc. Pharmacol., 2000, vol. 35, no. 6, pp. 863–870.
Docherty, J.R., An Investigation of the Effects of Intravenous Injection of the 5-Hydroxytryptamine 2 Receptor Antagonists Ketanserin and LY 53857 on Blood Pressure in Anesthetized Spontaneously Hypertensive Rats, J. Pharmacol Exp. Ther., 1989, vol. 248, no. 2, pp. 736–740.
Gradin, K., Pettersson, A., Hedner, T., et al., Antihypertensive Effects of Ketanserin in the Spontaneously Hypertensive Rat: Mode of Action, J. Cardiovasc. Pharmacol., 1985, vol. 7, suppl. 7, pp. 110–111.
Hedner, T. and Persson, B., Experience with Ketanserin and Ritanserin in Hypertensive Patients, J. Cardiovasc. Pharmacol., 1988, vol. 11,suppl. 1, pp. 44–48.
Hempelmann, R.G., Pradel, R.H., Mehdorn, H.M., et al., Threshold Concentrations of Endothelin-1: the Effects on Contractions Induced by 5-Hydroxytryptamine in Isolated Rat Cerebral and Mesenteric Arteries, Pharmacol. Toxicol., 1999, vol. 85, no. 3, pp. 115–122.
Heusler, P., Pauwels, P.J., Wurch, T., et al., Differential Ion Current Activation by Human 5-HT(1a) Receptors in Xenopus Oocytes: Evidence for Agonist-Directed Trafficking of Receptor Signalling, Neuropharmacology, 2005, vol. 49,no. 7, pp. 963–976.
Hosie, J., Stott, D.J., Robertson, J.I., et al., Does Acute Serotonergic Type-2 Antagonism Reduce Blood Pressure? Comparative Effects of Single Doses of Ritanserin and Ketanserin in Essential Hypertension, J. Cardiovasc. Pharmacol., 1987, vol. 10Suppl 3, pp. 86–88.
Huguet, F. and Brisac, A.M., Central 5HT1A-Receptor Binding in Normotensive and Spontaneously Hypertensive Rats, Fundam. Clin. Pharmacol., 1991, vol. 5,no. 3, pp. 259–262.
Kozhevnikova, L.M. and Avdonin, P.V., Agonist of Serotonin 5HT1A-Receptors 8-OH-DPAT Increases the Force of Contraction of Rat Aorta and Mesenteric Artery in the Presence of Endothelin-1 or Vasopressin and Causes Relaxation of the Vessels Preconstricted with Noradrenaline, Izv. Akad. Nauk, Ser. Biol., 2010, no. 1, pp. 1–10 [Biol. Bull., 2010, vol. 37, no. 1, pp. 35–43].
Kozhevnikova, L.M. and Avdonin, P.V., Disturbances in Hormonal Regulation of Vascular Tone During Traumatic Shock, Byull. Eksp. Biol. Med., 2006, no. 5, pp. 511–515.
Kozhevnikova, L.M., Davydova, A.G., and Avdonin, P.V., Plasma Membrane Depolarization and Activation of Receptors for Endogenous Vasoconstrictors as Possible Mechanisms of Potentiation of Vasoconstrictive Response to Serotonin in Traumatic Shock in Rats, Izv. Akad. Nauk, Ser. Biol., 2009, no. 3, pp. 343–357 [Biol. Bull., 2009, vol. 36, no. 3, pp. 285–297].
Lebrec, D., Portal Hypertension: Serotonin and Pathogenesis, Cardiovasc Drugs Ther., 1990, vol. 4,suppl. 1, pp. 33–35.
Melchiorre, C., Bolognesi, M.L., Budriesi, R., et al., Search for Selective Antagonists at alpha 1-Adrenoreceptors: Neutral or Negative Antagonism?, Farmaco, 1998, vol. 53, no. 4, pp. 278–286.
Nakayama, K., Ishigai, Y., Uchida, H., et al., Potentiation by Endothelin-1 of 5-Hydroxytryptamine-Induced Contraction in Coronary Artery of the Pig, Br. J. Pharmacol., 1991, vol. 104, no. 4, pp. 978–986.
Pediani, J., MacKenzie, J., Heeley, R., et al., Single-Cell Recombinant Pharmacology: Bovine alpha(1a)-Adrenoceptors in Rat-1 Fibroblasts Release Intracellular Ca(2+), Display Subtype-Characteristic Agonism and Antagonism, and Exhibit an Antagonist-Reversible Inverse Concentration-Response Phase, J. Pharmacol. Exp. Ther., 2000, vol. 293, no. 3, pp. 887–895.
Persson, B., Gradin, K., Pettersson, A., et al., Antihypertensive Effects of Ketanserin and Ritanserin in the Spontaneously Hypertensive Rat, J. Cardiovasc. Pharmacol., 1988, vol. 11,suppl. 1, pp. 22–24.
Pettersson, A., Gradin, K., Hedner, T., et al., Antihypertensive Mechanism of Action of Ketanserin and Some Ketanserin Analogues in the Spontaneously Hypertensive Rat, Naunyn Schmiedebergs Arch. Pharmacol., 1985, vol. 329, no. 4, pp. 394–397.
Rapport, M.M., Green, A.A., and Page, I.H., Partial Purification of the Vasoconstrictor in Beef Serum, J. Biol. Chem., 1948, vol. 174, no. 2, pp. 735–741.
Smits, J., van Dorsten, F., and Struyker Boudier, H., Interference of Ketanserin with Baroreflex Control of the Circulation in the Conscious Spontaneously Hypertensive Rat, Drugs, 1988, vol. 36,suppl. 1, pp. 55–60.
Soslau, G., Silverberg, M., Brodsky, I., et al., ATP Modification of Serotonin-Induced Contraction of the Rat Pulmonary Artery, Proc. Soc. Exp. Biol. Med., 1997, vol. 214,no. 3, pp. 233–241.
Villalobos-Molina, R., Lopez-Guerrero, J.J., and Ibarra, M., The Hypotensive Effect of BMY 7378 Is Antagonized by a Silent 5-HT(1A) Receptor Antagonist: Comparison with 8-Hydroxy-Dipropylamino Tetralin, Arch. Med. Res., 2001, vol. 32, no. 5, pp. 389–393.
Villalobos-Molina, R., Orozco-Mendez, M., Lopez-Guerrero, J.J., et al., WAY 405, a New Silent 5-HT (1A) Receptor Antagonist with Low Affinity for Vascular alpha (1)-Adrenoceptors, Auton. Autacoid Pharmacol., 2005, vol. 25,no. 4, pp. 185–189.
Watts, S.W. and Fink, G.D., 5-HT2B-Receptor Antagonist, LY-272015 Is Antihypertensive in DOCA-Salt-Hypertensive Rats, Am. J. Physiol., 1999, vol. 276, no. 3, pp. H944–H952.
Watts, S.W., 5-Hydroxytryptamine-Induced Potentiation of Endothelin-1and Norepinephrine-Induced Contraction Is Mitogen-Activated Protein Kinase Pathway Dependent, Hypertension, 2000, vol. 35, no. 1, pp. 244–248.
Watts, S.W., Baez, M., and Webb, R.C., The 5-Hydroxytryptamine2B Receptor and 5-HT Receptor Signal Transduction in Mesenteric Arteries from Deoxycorticosterone Acetate-Salt Hypertensive Rats, J. Pharmacol. Exp. Ther., 1996, vol. 277, no. 2, pp. 1103–1113.
Watts, S.W., Fink, G.D., Silver, P.J., et al., Interaction of the beta Adrenergic Receptor Antagonist Bucindolol with Serotonergic Receptors, J. Cardiovasc. Pharmacol., 2000, vol. 35, no. 1, pp. 29–36.
Yang, B.C., Nichols, W.W., Lawson, D.L., et al., 5-Hydroxytryptamine Potentiates Vasoconstrictor Effect of Endothelin-1, Am. J. Physiol., 1992, vol. 262, no. 4, pp. 931–936.
Yildiz, O., Smith, J.R., and Purdy, R.E., Serotonin and Vasoconstrictor Synergism, Life Sci., 1998, vol. 62, no. 19, pp. 1723–1732.
Zhu, J., Taniguchi, T., Takauji, R., et al., Inverse Agonism and Neutral Antagonism at a Constitutively Active alpha-1a Adrenoceptor, Br. J. Pharmacol., 2000, vol. 131, no. 3, pp. 546–552.
Zwieten, van P.A. and Bruning, T.A., Comparison of the Hemodynamic Effects of Urapidil and Flesinoxan in Healthy Volunteers, Blood Press., 1994, vol. 4, pp. 19–24.
Zwieten, van P.A., Blauw, G.J., and van Brummelen, P., Pharmacological Profile of Antihypertensive Drugs with Serotonin Receptor and alpha-Adrenoceptor Activity, Drugs, 1990, vol. 40,suppl. 4, pp. 1–8.
Zwieten, van P.A., Blauw, G.J., and van Brummelen, P., Serotonergic Receptors and Drugs in Hypertension, Pharmacol. Toxicol., 1992, vol. 70, no. 6, pp. 17–22.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.M. Kozhevnikova, I.F. Sukhanova, P.V. Avdonin, 2011, published in Izvestiya Akademii Nauk, Seriya Biologicheskaya, 2011, No. 1, pp. 68–76.
Rights and permissions
About this article
Cite this article
Kozhevnikova, L.M., Sukhanova, I.F. & Avdonin, P.V. Activation of “silent” vasoconstrictive 5-HT1A receptors as a possible mechanism of synergism in angiotensin II and serotonin effect on vascular tone. Biol Bull Russ Acad Sci 38, 57–64 (2011). https://doi.org/10.1134/S1062359011010079
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1062359011010079